Boston Scientific stock is up as Farapulse drives Q1 beat, raised guidance

Boston Scientific (NYSE: BSX) shares got a boost this morning on first-quarter results that came in ahead of the consensus forecast. Read More

Boston Scientific sees 70% electrophysiology growth after Farapulse pulsed-field ablation launch

As a whole, Boston Scientific reported a 13.8% increase in quarterly revenue, for $3.86 billion in net sales. That outpaced the company’s previous financial guidance that forecasted 7% to 9% ... Read More

Boston Scientific Q1 Earnings and Revenues Top Estimates

Boston Scientific (NYSE: BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago. Read More

Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales

Shares of Boston Scientific ( BSX) hit an all-time high Wednesday as the maker of medical equipment reported better-than-anticipated quarterly results and boosted its guidance on demand for its ... Read More

Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidance

Boston Scientific Corp.’s stock rose 7% Wednesday to put it on track for a fresh record high after the medical-tech company beat analyst estimates for first-quarter earnings and offered upbeat ... Read More

FTC asks Boston Scientific, Axonics for more info on their $3.7B deal, pushing back acquisition timeline

The Federal Trade Commission (FTC) is taking a closer look at Boston Scientific’s $3.7 billion proposal to acquire neuromodulation developer Axonics, a move that could push back the closing of ... Read More

Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics

Revenues are expected to be $3.68 billion, up ... Boston Scientific shares have witnessed a change of -0.2% in the past month, in contrast to the Zacks S&P 500 composite's -2.6% move. Read More

FDA classifies recall of Boston Scientific device as 'most serious'

(Reuters) -The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device ... The health regulator said there were 11 incidents reported, seven injuries ... Read More

Boston Scientific Corp Q1 Profit Increases, beats estimates

Boston Scientific Corp (BSX) revealed a profit for its first quarter that increased from the same period last year and beat the ... Read More

What's in Store for Boston Scientific (BSX) in Q1 Earnings?

Boston Scientific Corporation BSX is scheduled to report first-quarter 2024 results on Apr 24, before the opening bell. In the last reported quarter, the company’s earnings per share of 55 cents ... Read More

FDA classifies recall of Boston Scientific device as 'most serious'

(Reuters) -The U.S. Food and ... health regulator said there were 11 incidents reported, seven injuries, and two deaths related to this issue. The recall is a correction, not a product removal, the ... Read More

Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics

Revenues are expected to be $3.68 billion, up 8.5% from the year-ago quarter. Over the last 30 days, there ... let's now explore the average estimates of specific Boston Scientific metrics that ... Read More